News for 'Good Manufacturing Practice'

Why So Much Hatred For English?

Why So Much Hatred For English?

Rediff.com21 Jul 2025

There is no guarantee that if we speak in only Indian languages, all our faults will be washed away and India will shine. Why then do they bully and belittle the English-speaking? asks Shyam G Menon.

USFDA issues import alert on Ranbaxy's Mohali plant

USFDA issues import alert on Ranbaxy's Mohali plant

Rediff.com16 Sep 2013

While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.

Which is the new battleground in tax disputes?

Which is the new battleground in tax disputes?

Rediff.com25 Jun 2025

In October 2024, Jindal Stainless challenged a Goods and Services Tax (GST) notice in the Delhi high court. It was about corporate guarantees issued to related parties by its former group company, Jindal Stainless (Hisar), before their merger in March 2023.

Trump's Tariff Tsunami: Will India Sink or Reform?

Trump's Tariff Tsunami: Will India Sink or Reform?

Rediff.com21 Apr 2025

The Trump trade shock is a chance to push long-overdue reforms, rather than tinker with tariffs to appease the US, suggests M Govinda Rao.

US drug regulator warns RPG Life Sciences

US drug regulator warns RPG Life Sciences

Rediff.com19 Jun 2013

The US Food and Drug Administration (USFDA) has issued a warning letter to RPG Life Sciences for violation of current good manufacturing practice (CGMP) norms at its two plants at Ankleshwar and Mumbai.

After US, Germany bans export of Ranbaxy's Dewas plant drugs

After US, Germany bans export of Ranbaxy's Dewas plant drugs

Rediff.com3 Dec 2014

The company did not comply to the 'good manufacturing practice' norms.

Wockhardt gets import alert from US FDA

Wockhardt gets import alert from US FDA

Rediff.com6 Aug 2016

Ankleshwar plant is the third such facility to face action

WHO suspends Covaxin supply to UN agencies

WHO suspends Covaxin supply to UN agencies

Rediff.com3 Apr 2022

A statement issued by the WHO on Saturday said the suspension is in response to the outcomes of its post EUL (emergency use authorisation) inspection held between March 14-22, 2022 and the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.

There will be some pain: Trump's message to Americans

There will be some pain: Trump's message to Americans

Rediff.com3 Feb 2025

United States President Donald Trump on Sunday criticised the trade deficits that the US has with Canada, Mexico, China, and argued that America should no longer 'subsidise' other countries, and urged businesses to manufacture domestically to avoid tariffs.

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy 'systematically violated' norms: Whistleblower

Rediff.com14 May 2013

The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India and included acne drug Sotret, epilepsy and nerve pain drug gabapentin and antibiotic ciprofloxacin.

Budget 2025: More Jobs Via Thriving Farms and MSME Growth

Budget 2025: More Jobs Via Thriving Farms and MSME Growth

Rediff.com4 Feb 2025

The most striking features of this Budget was its focus on simplification and improving the ease of doing business in India, asserts Kaku Nakhate.

Sun Pharma's US subsidiary to cut jobs

Sun Pharma's US subsidiary to cut jobs

Rediff.com30 Jul 2009

Earlier last month US FDA officials had seized drug products manufactured by Caraco Pharmaceutical at its Michigan facilities in Detroit, Farmington Hills, and Wixom, alleging violation in good manufacturing practice.

FDA warns Ranbaxy's American subsidiary

FDA warns Ranbaxy's American subsidiary

Rediff.com24 Dec 2009

The letter mentions certain cGMP violation based on site inspections conducted between July and August 2009.

US regulator not happy with Sun Pharma's reply on import alert

US regulator not happy with Sun Pharma's reply on import alert

Rediff.com21 May 2014

In March, the FDA had issued an import alert, banning formulations and active pharmaceutical ingredients from the factory.

US Firms Back Trump's India Tariffs

US Firms Back Trump's India Tariffs

Rediff.com31 Mar 2025

Industry associations and companies in the United States, including the US Chamber of Commerce, Coalition of Services Industries and the iconic bike company Harley Davidson have called on the Donald Trump dispensation to push India to reduce tariffs, non-tariffs, and regulatory barriers to boost American exports.

Budget: Auto cos eye 10m beneficiaries of no-tax rule

Budget: Auto cos eye 10m beneficiaries of no-tax rule

Rediff.com4 Feb 2025

According to experts, even if an additional 5 per cent of people opt to buy new vehicles, it may bring a huge boost to the sector.

US FDA tightens screws on sale of diet supplements

US FDA tightens screws on sale of diet supplements

Rediff.com29 Jun 2007

The US Food and Drug Administration has tightened rules for selling dietary supplements in the US market, making compliance with current good manufacturing practices mandatory for manufacturers.

50 million doses of Covaxin set to expire in 2023

50 million doses of Covaxin set to expire in 2023

Rediff.com6 Nov 2022

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

Small drug makers face closure

Small drug makers face closure

Rediff.com29 Dec 2003

Osamu Suzuki, the man who spurred India's auto industry is dead

Osamu Suzuki, the man who spurred India's auto industry is dead

Rediff.com27 Dec 2024

Osamu Suzuki, the man who took a risk and bet on India when no one else believed in having a viable automobile company in the country, has died at the age of 94, according to information shared by Japan's Suzuki Motor Corporation on Friday.

Trump Has Become A Reset Button

Trump Has Become A Reset Button

Rediff.com11 Apr 2025

Trump's sweeping tariffs and penalties on China-built ships have turned global shipping into the front line of economic war, observes Shyam G Menon.

Dr Reddy's sued in US court by S Korean pharma co

Dr Reddy's sued in US court by S Korean pharma co

Rediff.com27 Jan 2017

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator.

Companies Plan Yoga Day Celebration

Companies Plan Yoga Day Celebration

Rediff.com21 Jun 2024

'An in-house contest encourages employees to share yoga and well-being practices with their families.'

UK warning to affect herbal exports

UK warning to affect herbal exports

Rediff.com24 Aug 2005

The warnings issued by Britain and Canada against the use of some Indian herbal medicines on the ground that they contain dangerous levels of heavy metals, may affect the export of medicinal plants in the global market.

Good News For Android App Developers

Good News For Android App Developers

Rediff.com30 Dec 2023

For many developers, it may not be a sufficient saving to make it worth creating and maintaining alternatives.

AI will play big role here: Google India MD

AI will play big role here: Google India MD

Rediff.com3 Oct 2024

Having marked a 20-year milestone in India, global tech giant Google is upbeat about its next innings here with Artificial Intelligence (AI) playing a big role in it, India MD Roma Datta Chobey said on Thursday, adding that the company is aligning its vision and strategy fully to the country's growth and ambitions. In an interview to PTI, Chobey said Google believes that AI should be regulated but in a way that strikes a fine balance between user benefit -- which is "still at a nascent stage" -- and at the same time, fosters innovation.

USFDA issues warning against Cadila Pharmaceuticals

USFDA issues warning against Cadila Pharmaceuticals

Rediff.com12 Nov 2014

The FDA issued the letter on October 15, and has given the company 15 days to respond.

Budget 2025: What realtors want from Nirmala Sitharaman

Budget 2025: What realtors want from Nirmala Sitharaman

Rediff.com13 Jan 2025

As the Union Budget 2025-2026 (FY26) inches closer, the Indian real estate industry is seeking stamp duty cuts, revised home loan limits and updated affordable housing norms through Pradhan Mantri Awas Yojna (PMAY), single-window clearance and eco-friendly policies, among others. Industry leaders and consultancy firms, including Anarock, Raheja, Gaurs, Kanodia Group, Reach, Urban Space, Justo and Eros Group, have shared their expectations.

Wockhardt hit by FDA alert on another plant

Wockhardt hit by FDA alert on another plant

Rediff.com27 Nov 2013

Its factory in Chikalthana in western India was last month hit by the British drug regulator's curb on imports from the plant over manufacturing deficiencies.

Trump 47: Disruptor Or Savvy Dealmaker?

Trump 47: Disruptor Or Savvy Dealmaker?

Rediff.com21 Jan 2025

Donald Trump's exaggerated opinion of his dealmaking capacity can get him into trouble, observes R Sriram.

'Most countries won't forgive deaths of children'

'Most countries won't forgive deaths of children'

Rediff.com22 Nov 2022

'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'

Investors concerned about Wockhardt

Investors concerned about Wockhardt

Rediff.com17 Oct 2013

The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.

Local suppliers, MNCs voice concerns over DPIIT's Make in India push

Local suppliers, MNCs voice concerns over DPIIT's Make in India push

Rediff.com1 Mar 2024

The Department for Promotion of Industry and Internal Trade (DPIIT) has proposed to raise the minimum local content under public procurement order in government contracts. But several local suppliers and multinational companies (MNCs) are saying such a steep target is not attainable. Class-I suppliers, whose goods, services or works offered for procurement has local content equal to or more than 50 per cent may see it hiked to 70 per cent, while it may go up to 50 per cent from 20 per cent for Class-II suppliers.

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

Countdown Begins To Budget 2025

Countdown Begins To Budget 2025

Rediff.com7 Dec 2024

It will be the second Budget of the Modi 3.0 government and eighth straight Budget for Nirmala Sitharaman, rare in Indian polity.

Trump's Tariff Tussle With India

Trump's Tariff Tussle With India

Rediff.com6 Nov 2024

'While criticising India's high tariffs, Mr Trump stated he would impose reciprocal taxes on Indian products if re-elected.' 'However, since India's tariffs follow WTO rules, Mr Trump's actions would violate these rules,' Ajay Srivastava points out.

5 Workplace Changes You Will See in 2025

5 Workplace Changes You Will See in 2025

Rediff.com2 Jan 2025

Workplaces of 2025 will be defined by a deep focus on people-first values, inclusivity, and sustainable growth, foresees Sonica Aron, founder of Marching Sheep.